Trading of Opko Health Inc. shares on Nasdaq was halted by the exchange on Sept. 7 and the company said on Sept. 11 that trading will not resume until the company provides a satisfactory response to Nasdaq's questions about a US Securities and Exchange Commission (SEC) lawsuit alleging that Opko and its Chairman and CEO Phillip Frost participated in pump-and-dump stock trading schemes.
The company and Frost said in a statement issued soon after the SEC filed its civil complaint on Sept. 7...






